A Phase 2b, Single-Arm, Open-Label, Multicenter Study of the Safety of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

Study Summary

This study will assess the safety and tolerability of SPK-8011QQ in adult males with moderately severe to severe hemophilia A.

Interventions

Study Locations

Facility	City	State	Country
Kaiser Permanente	Vallejo	California	United States

Official Trial Information

View on ClinicalTrials.gov